Stocks
Ocugen, Inc.OCGN
NASDAQHealthcareBiotechnology$2.48+5.98%
A clinical-stage biotechnology company focused on developing gene and cell therapies for rare eye diseases and other serious conditions. Its pipeline includes experimental treatments targeting inherited retinal disorders and biologics platforms, with progress tied closely to clinical trial outcomes ...
Market Cap: $813.2M52W Range: $0.52 – $2.67
This page tracks all publicly disclosed congressional trades in Ocugen, Inc. (OCGN), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-06-16 | Christopher L. Jacobs | buy | $15K – $50K |